Our data showed that IL-6, IL-12, and TNF associated with insufficient IL-10 modulation might favor liver inflammation, leading to development of metabolic disturbances and increasing the chances of liver damage associated with fibrosis during the progression of NAFLD. The gene discussed is IL10; the disease is metabolic dysfunction-associated steatotic liver disease.